Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05783791 · ClinicalTrials.gov registry record
Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 11
- Enrollment target
NCT05783791 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 11 participants.
The verdict
NCT05783791 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
The overall purpose of this project is to establish the capability of screening for Angelman syndrome (AS) and Prader-Willi syndrome (PWS) in public health newborn screening (NBS) programs, with an aim of developing and validating a screening test for AS and PWS.
Interventions
- DIAGNOSTIC_TEST Newborn Screening Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2023-07-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05783791
The ClinicalTrials.gov registry entry for NCT05783791 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Newborn Screening Assay is the first listed.
NCT05783791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05783791 about?
NCT05783791 is a clinical study titled "Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome". The overall purpose of this project is to establish the capability of screening for Angelman syndrome (AS) and Prader-Willi syndrome (PWS) in public health newborn screening (NBS) programs, with an aim of developing and validating a screening test for AS and PWS.
What is the current status of trial NCT05783791?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2023-04-20. Estimated completion is 2023-07-21.
What interventions are being tested in trial NCT05783791?
The interventions under investigation include: Newborn Screening Assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05783791?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.